[go: up one dir, main page]

SG11201810633WA - New fluorescent dyes and their uses as biomarkers - Google Patents

New fluorescent dyes and their uses as biomarkers

Info

Publication number
SG11201810633WA
SG11201810633WA SG11201810633WA SG11201810633WA SG11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA
Authority
SG
Singapore
Prior art keywords
international
ffc
chesterford
pct
essex
Prior art date
Application number
SG11201810633WA
Inventor
Nikolai Romanov
Original Assignee
Illumina Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumina Cambridge Ltd filed Critical Illumina Cambridge Ltd
Publication of SG11201810633WA publication Critical patent/SG11201810633WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B62/00Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves
    • C09B62/02Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring
    • C09B62/36Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring to some other heterocyclic ring
    • C09B62/365Specific dyes not provided for in groups C09B62/38 - C09B62/42
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1 Ill 11111 0 11101 HOE HI 1 0 0111011001111111101011 MEV OEN Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\"1 WO 2018/060482 Al 05 April 2018 (05.04.2018) WIP0 I PCT (51) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) (71) Applicant: (72) Inventor: ROMANOV, Nikolai; International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 417/04 (2006.01) A61K 49/10 (2006.01) kind of national protection available): AE, AG, AL, AM, CO7D 491/04 (2006.01) CO9K 11/06 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, PCT/EP2017/074880 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 29 September 2017 (29.09.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. Priority Data: (84) Designated States (unless otherwise indicated, for every 62/402,635 30 September 2016 (30.09.2016) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, ILLUMINA CAMBRIDGE LIMITED UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, [GB/GB]; Chesterford Research Park, Little Chesterford, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Nr. Saffron Walden Essex CB10 1XL (GB). EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, c/o Illumina Cambridge MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, Limited, Chesterford Research Park, Little Chesterford, Nr. TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Saffron Walden Essex CB10 1XL (GB). KM, ML, MR, NE, SN, TD, TG). Agent: MURGITROYD & COMPANY; Scotland House, Declarations under Rule 4.17: 165-169 Scotland Street, Glasgow Strathclyde G5 8PL _ as to applicant's entitlement to apply for and be granted a (GB). patent (Rule 4.1700) (74) = = = = D O V , CD °, Z n 0 1 —i 0 0 a c. , 0 .., m0 C/ ) n r r l Fluorescen Inte t ns ity ( Ar bitrary Un it) g Z n = H co 2, R ( o DYES AND THEIR USES AS BIOMARKERS / R ) R N g i R3 0 0 N I R2 R 4 (I) labels. The compounds may be (54) = = = = = = 1 © © -.... 1-1 N (57) _ used 250 200 150 100 50 0 -• r • 0 \ \ . . ill 11. \ \\ / 4 1 \ .\\ i / 0 \\ \ \\ / \ . • 6 1 4 \\ \.\\ \ \ \‘• \ \ • \ s \• \\\,'• — ffc-star440sx — — ffc-1-9 -- ffc-I-10 --- ffc-1-6 ---- ffc-1-1 470 520 570 620 670 720 770 Wavelength (nm) \" 171c 1 relates to new fluorescent dyes and their uses as fluorescent in nucleic acid sequencing applications. [Continued on next page] WO 2018/060482 Al 11111111111111011101010111110111010111110110011111111111101011111110110111111 Published: — with international search report (Art. 21(3))
SG11201810633WA 2016-09-30 2017-09-29 New fluorescent dyes and their uses as biomarkers SG11201810633WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662402635P 2016-09-30 2016-09-30
PCT/EP2017/074880 WO2018060482A1 (en) 2016-09-30 2017-09-29 New fluorescent dyes and their uses as biomarkers

Publications (1)

Publication Number Publication Date
SG11201810633WA true SG11201810633WA (en) 2018-12-28

Family

ID=60268333

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810633WA SG11201810633WA (en) 2016-09-30 2017-09-29 New fluorescent dyes and their uses as biomarkers

Country Status (11)

Country Link
US (3) US10385214B2 (en)
EP (2) EP3974425B1 (en)
JP (2) JP7002478B2 (en)
KR (2) KR102473054B1 (en)
CN (1) CN109476654B (en)
AU (2) AU2017335223B2 (en)
CA (1) CA3026019C (en)
ES (2) ES2988726T3 (en)
IL (2) IL297749B2 (en)
SG (1) SG11201810633WA (en)
WO (1) WO2018060482A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10385214B2 (en) 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
GB201716931D0 (en) * 2017-10-16 2017-11-29 Illumina Cambridge Ltd New fluorescent compounds and their use as biomarkers
CN112601825B (en) * 2018-07-09 2023-11-28 青岛华大智造科技有限责任公司 Nucleic acid sequencing method
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
WO2020178231A1 (en) 2019-03-01 2020-09-10 Illumina, Inc. Multiplexed fluorescent detection of analytes
NL2023327B1 (en) * 2019-03-01 2020-09-17 Illumina Inc Multiplexed fluorescent detection of analytes
CA3103900A1 (en) * 2019-03-01 2020-09-10 Illumina Cambridge Limited Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels
KR102865446B1 (en) * 2019-03-01 2025-09-29 일루미나 케임브리지 리미티드 Tertiary amine-substituted coumarin compounds and their use as fluorescent labels
IL292961B2 (en) 2019-11-27 2024-01-01 Illumina Cambridge Ltd Cyclotetraenes contain dyes and their compounds
CN120174072A (en) 2020-06-22 2025-06-20 伊鲁米纳剑桥有限公司 Nucleosides and nucleotides with 3' acetal capping groups
US11981964B2 (en) 2020-07-28 2024-05-14 Illumina Cambridge Limited Substituted coumarin dyes and uses as fluorescent labels
US20220195516A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
US20220195196A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Alkylpyridinium coumarin dyes and uses in sequencing applications
US20220195517A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
US20220195518A1 (en) 2020-12-22 2022-06-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
CN114671842B (en) * 2020-12-24 2024-05-28 郑州思昆生物工程有限公司 Fluorescent compound, preparation method thereof, fluorescent modified nucleotide and kit
WO2022243480A1 (en) 2021-05-20 2022-11-24 Illumina, Inc. Compositions and methods for sequencing by synthesis
US20220403450A1 (en) 2021-06-03 2022-12-22 Illumina Software, Inc. Systems and methods for sequencing nucleotides using two optical channels
KR20240049214A (en) 2021-09-01 2024-04-16 일루미나, 인코포레이티드 Amplitude modulation for accelerated base calling
US20230183799A1 (en) 2021-12-10 2023-06-15 Illumina, Inc. Parallel sample and index sequencing
WO2023175021A1 (en) 2022-03-15 2023-09-21 Illumina, Inc. Methods of preparing loop fork libraries
CA3223115A1 (en) 2022-03-28 2023-10-05 Xiaolin Wu Labeled avidin and methods for sequencing
CA3223125A1 (en) 2022-03-29 2023-10-05 Illumina, Inc. Chromenoquinoline dyes and uses in sequencing
EP4499870A1 (en) 2022-03-31 2025-02-05 Illumina, Inc. Compositions and methods for improving sequencing signals
EP4499659A1 (en) 2022-03-31 2025-02-05 Illumina, Inc. Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis
AU2023281871A1 (en) 2022-05-31 2024-11-14 Illumina, Inc Compositions and methods for nucleic acid sequencing
CN119604513A (en) 2022-06-28 2025-03-11 因美纳公司 Fluorescent dyes containing fused tetracyclic biboronic heterocycles and their use in sequencing
EP4594428A2 (en) 2022-09-30 2025-08-06 Illumina, Inc. Compositions and methods for reducing photo damage during sequencing
WO2024137774A1 (en) 2022-12-22 2024-06-27 Illumina, Inc. Palladium catalyst compositions and methods for sequencing by synthesis
CN119095983A (en) 2022-12-22 2024-12-06 伊路米纳有限公司 Transition metal catalyst compositions and methods for sequencing by synthesis
EP4642931A1 (en) 2022-12-27 2025-11-05 Illumina, Inc. Methods of sequencing using 3´ allyl blocked nucleotides
CN119452044A (en) 2023-03-29 2025-02-14 因美纳公司 Naphthalimide dyes and their use in nucleic acid sequencing
US20240327909A1 (en) 2023-03-30 2024-10-03 Illumina, Inc. Compositions and methods for nucleic acid sequencing
WO2025049700A1 (en) 2023-08-31 2025-03-06 Illumina, Inc. Compositions and methods for nucleic acid sequencing
WO2025061922A1 (en) 2023-09-20 2025-03-27 Illumina, Inc. Methods for sequencing
WO2025061942A1 (en) 2023-09-20 2025-03-27 Illumina, Inc. Sequencing error identification and correction
WO2025090596A1 (en) 2023-10-26 2025-05-01 Illumina, Inc. 4,5-substituted naphthalimide dyes and uses in nucleic acid sequencing
WO2025144716A1 (en) 2023-12-28 2025-07-03 Illumina, Inc. Nucleotides with enzymatically cleavable 3'-o-glycoside blocking groups for sequencing
WO2025184226A1 (en) 2024-02-28 2025-09-04 Illumina, Inc. Nucleotides with terminal phosphate capping
WO2025188906A1 (en) 2024-03-08 2025-09-12 Illumina, Inc. Modified adenosine nucleotides
WO2025221895A1 (en) 2024-04-19 2025-10-23 Illumina, Inc. Water soluble polymer scaffolds for dye labeling
WO2025230914A1 (en) 2024-04-29 2025-11-06 Illumina, Inc. Nucleotides with enzyme-triggered self-immolative linkers for sequencing by synthesis

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411969A1 (en) * 1974-03-13 1975-09-25 Bayer Ag DYE LASER
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5846719A (en) 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
JP2002503954A (en) 1997-04-01 2002-02-05 グラクソ、グループ、リミテッド Nucleic acid amplification method
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
GB0002310D0 (en) 2000-02-01 2000-03-22 Solexa Ltd Polynucleotide sequencing
IL141148A0 (en) 1998-07-30 2002-02-10 Solexa Ltd Arrayed biomolecules and their use in sequencing
AR021833A1 (en) 1998-09-30 2002-08-07 Applied Research Systems METHODS OF AMPLIFICATION AND SEQUENCING OF NUCLEIC ACID
US6391937B1 (en) 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
US6169185B1 (en) 1999-02-25 2001-01-02 Day-Glo Color Corp. Ink jet printing inks
US6372813B1 (en) 1999-06-25 2002-04-16 Motorola Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
US6664061B2 (en) 1999-06-25 2003-12-16 Amersham Biosciences Ab Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
EP1307414A2 (en) 2000-08-09 2003-05-07 Amersham Biosciences AB The use and evaluation of a 2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
DE60327649D1 (en) 2002-08-23 2009-06-25 Illumina Cambridge Ltd MARKED NUCLEOTIDE
EP3795577A1 (en) 2002-08-23 2021-03-24 Illumina Cambridge Limited Modified nucleotides
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
GB0326073D0 (en) 2003-11-07 2003-12-10 Solexa Ltd Improvements in or relating to polynucleotide arrays
EP3175914A1 (en) 2004-01-07 2017-06-07 Illumina Cambridge Limited Improvements in or relating to molecular arrays
US8623628B2 (en) 2005-05-10 2014-01-07 Illumina, Inc. Polymerases
GB0517097D0 (en) 2005-08-19 2005-09-28 Solexa Ltd Modified nucleosides and nucleotides and uses thereof
WO2007135368A2 (en) 2006-05-18 2007-11-29 Solexa Limited Dye compounds and the use of their labelled conjugates
WO2013041117A1 (en) 2011-09-23 2013-03-28 Illumina Cambrigde Ltd. Dyes for labelling molecular ligands
CA2859660C (en) 2011-09-23 2021-02-09 Illumina, Inc. Methods and compositions for nucleic acid sequencing
US9012022B2 (en) 2012-06-08 2015-04-21 Illumina, Inc. Polymer coatings
CN105263918B (en) * 2013-03-08 2018-05-18 伊鲁米纳剑桥有限公司 Rhodamine compound and its purposes as fluorescent marker
BR112015022448B1 (en) 2013-03-15 2020-12-08 Illumina Cambridge Limited modified nucleotide or nucleoside molecule, methods for preparing the growth of polynucleotide complementary to single-stranded target polynucleotide in sequencing reaction and to determine the sequence of single-stranded target polynucleotide and kit
US10385214B2 (en) * 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers

Also Published As

Publication number Publication date
NZ748812A (en) 2020-11-27
CN109476654A (en) 2019-03-15
US20210071005A1 (en) 2021-03-11
IL297749B2 (en) 2025-10-01
US10844225B2 (en) 2020-11-24
ES2988726T3 (en) 2024-11-21
CN109476654B (en) 2022-06-10
AU2022268273A1 (en) 2022-12-15
CA3026019C (en) 2022-05-17
IL297749A (en) 2022-12-01
AU2022268273B2 (en) 2024-06-13
JP2019531255A (en) 2019-10-31
KR20190057021A (en) 2019-05-27
EP3974425A1 (en) 2022-03-30
EP3519410A1 (en) 2019-08-07
AU2017335223B2 (en) 2022-08-11
JP2022050495A (en) 2022-03-30
IL263871B (en) 2022-12-01
US11370920B2 (en) 2022-06-28
AU2017335223A1 (en) 2018-12-20
ES2914688T3 (en) 2022-06-15
IL263871B2 (en) 2023-04-01
KR102582172B1 (en) 2023-09-22
EP3974425B1 (en) 2024-07-10
JP7002478B2 (en) 2022-02-10
WO2018060482A1 (en) 2018-04-05
US20180094140A1 (en) 2018-04-05
IL263871A (en) 2019-01-31
KR102473054B1 (en) 2022-11-30
EP3519410B1 (en) 2022-03-30
US10385214B2 (en) 2019-08-20
CA3026019A1 (en) 2018-04-05
KR20220160714A (en) 2022-12-06
IL297749B1 (en) 2025-06-01
US20190367738A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
SG11201810633WA (en) New fluorescent dyes and their uses as biomarkers
SG11201810611YA (en) Coumarin compounds and their uses as fluorescent labels
SG11201908820VA (en) Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201810983PA (en) Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201900746RA (en) Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions
SG11201809913PA (en) Methods for detecting target nucleic acids in a sample
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201901747VA (en) Inhibitors of cellular metabolic processes
SG11201809539RA (en) Covalently modified surfaces, kits, and methods of preparation and use
SG11201900883UA (en) Combination treatment for hematological cancers
SG11201906386XA (en) Combination therapy involving diaryl macrocyclic compounds
SG11201901658PA (en) Beta-lactamase inhibitor compounds
SG11201900200XA (en) Tgfb antibodies, methods, and uses
SG11201908743SA (en) Methods and compositions for modulation of immune cells
SG11201408451WA (en) Use of vacuum chucks to hold a wafer or wafer sub-stack
SG11201906413XA (en) Exposure apparatus
SG11201807596YA (en) Gitr antibodies, methods, and uses
SG11201908456VA (en) Linker units and molecular constructs comprising same
SG11201908091QA (en) Aqueous anti-pd-l1 antibody formulation
SG11202000331YA (en) Therapeutic modulators of the reverse mode of atp synthase
SG11201901873PA (en) Tablet compositions
SG11201811062XA (en) Cysteine engineered fibronectin type iii domain binding molecules
SG11201903091VA (en) Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors
SG11201903348UA (en) Therapeutic compounds and methods of use thereof
SG11201900589PA (en) Methods for gynecologic neoplasm diagnosis